We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PGR:NYSEProgressive Corporation (The) Analysis

Data as of 2026-05-26 - not real-time

$199.51

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Progressive (PGR) is trading near its 52‑week low of $191.75 with a current price just above $199, yet a discounted cash‑flow model values the company at roughly $489, implying a substantial upside. The stock trades at a forward P/E of about 12 versus an industry average of 16.8, and its dividend yield of nearly 7% is among the highest in the sector, supported by a payout ratio around 70% and strong free cash flow generation. Recent Q1 2026 results delivered $20.97 B in revenue, an 8% year‑over‑year increase that beat consensus, and operating margins remain robust at roughly 16%, contributing to a ROE of 38%. These fundamentals, combined with a low beta and an increasing volume trend, suggest the company is financially resilient despite a 30‑day volatility of over 21%. Technical indicators show a bearish trend direction, with the 20‑day SMA just below price and the 50‑day SMA above, while the MACD histogram turned positive, indicating a potential short‑term rebound. Overall, the valuation gap, solid earnings momentum, and attractive dividend profile outweigh the near‑term price weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bearish trend direction
  • MACD histogram turning positive
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Strong earnings growth and margin expansion
  • Robust cash flow supporting dividend sustainability

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistently high ROE and low debt‑to‑equity ratio
  • Industry‑leading profitability and market position
  • Attractive dividend yield with solid payout coverage

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin12.93%
P/E Ratio10.2
ROE37.90%
ROA7.94%
Debt/Equity26.17
P/B Ratio3.6
Op. Cash Flow$16.8B
Free Cash Flow$15.5B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI49.1
Support$191.75
Resistance$206.84
MA 20$199.28
MA 50$200.45
MA 200$218.82
MACDBullish
VolumeIncreasing
Fear & Greed Index91.34

Valuation

Fair Value$489.36
Target Price$230.71
Upside/Downside15.64%
GradeUndervalued
TypeValue
Dividend Yield6.97%

Risk Assessment

Beta-0.12
Volatility21.19%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.